You have 9 free searches left this month | to do more

bicalutamide

Bicalutamide is a drug used to treat Prostate Cancer, Prostate Adenocarcinoma, Prostatic Neoplasms, and other conditions. Bicalutamide is being actively studied in 37 studies and prior, has been studied in 57.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)University of Michigan Comprehensive Cancer CenterMary-Ellen Taplin, MD
AstraZenecaDecatur Memorial HospitalAjjai Alva, MD
Radiation Therapy Oncology GroupWest Michigan Cancer CenterAmy Tiersten
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Prostate Adenocarcinoma
  • bicalutamide
  • Stereotactic body radiation therapy
  • Bethesda, Maryland
    National Cancer Institute
2021-10-01
Oct 1, 2021
I
Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
2021-10-14
Oct 14, 2021
P
Recruiting
  • Breast Neoplasm Female
  • +3 more
  • Portland, Oregon
    Providence Oncology & Hematology Care Clinic - Eastside
2022-01-31
Jan 31, 2022
M
Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
2021-10-29
Oct 29, 2021
M
Completed
  • Breast Cancer
  • bicalutamide
  • +2 more
  • San Francisco, California
  • +7 more
2021-06-25
Jun 25, 2021
K
Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
2022-02-16
Feb 16, 2022
B
Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
2021-03-02
Mar 2, 2021
M
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • (no location specified)
2022-01-05
Jan 5, 2022
U
Completed
  • Breast Cancer
  • Bicalutamide
  • FDHT PET
  • Groningen, Netherlands
    University Medical Center Groningen
2019-11-26
Nov 26, 2019
S
Recruiting
  • Salivary Gland Neoplasms
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
2021-10-08
Oct 8, 2021
U
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Chicago, Illinois
    University of Chicago
2021-09-30
Sep 30, 2021
S
Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
2022-03-29
Mar 29, 2022
U
Active, not recruiting
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2021-12-27
Dec 27, 2021
M
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +7 more
  • Milwaukee, Wisconsin
    Froedtert Hospital
2021-02-17
Feb 17, 2021
S
Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
2021-10-11
Oct 11, 2021
D
Recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Stamford, Connecticut
  • +4 more
2022-03-28
Mar 28, 2022
R
Completed
  • Prostate Cancer
  • bicalutamide
  • +4 more
  • Toronto, Ontario, Canada
    Toronto Sunnybrook Regional Cancer Centre
2020-10-21
Oct 21, 2020
S
Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
2022-02-01
Feb 1, 2022
C
Active, not recruiting
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Bicalutamide
  • +4 more
  • Duarte, California
  • +1 more
2022-04-04
Apr 4, 2022
T
Recruiting
  • High-risk Prostate Cancer
  • Prostate Cancer
  • Houston, Texas
    Houston Methodist Hospital
2021-04-05
Apr 5, 2021
F
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2020-07-05
Jul 5, 2020
M
Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021
D
Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
2022-03-07
Mar 7, 2022
C
Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
2021-08-10
Aug 10, 2021
M
Withdrawn
  • Stage I Prostate Adenocarcinoma
  • Stage II Prostate Adenocarcinoma
  • Bicalutamide
  • +3 more
  • (no location specified)
2019-01-17
Jan 17, 2019